# Drugmonitoring of Antiinfective Drugs in Patients Receiving Continous Veno-venous Hemodiafiltration (ABx-CVVHDF)

> **NCT02242721** · — · WITHDRAWN · sponsor: **Charite University, Berlin, Germany**

## Conditions studied

- Need for Renal Replacement Therapy and Anti-infective Therapy Due to Severe Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02242721
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-10
- **Primary completion:** 2015-10
- **Final completion:** 2016-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242721, "Drugmonitoring of Antiinfective Drugs in Patients Receiving Continous Veno-venous Hemodiafiltration (ABx-CVVHDF)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02242721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*